 | • レポートコード：GIR-2104Z12166 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、RSV診断のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。RSV診断の種類別市場規模（キット・アッセイ、機器、その他）、用途別市場規模（病院＆診療所、臨床検査室、在宅ケア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・RSV診断の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：bioMérieux、Abbott、Roche、BD、Thermo Fisher、Luminex、Danaher、Biocartis、Hologic ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：キット・アッセイ、機器、その他 ・用途別分析2016年-2026年：病院＆診療所、臨床検査室、在宅ケア ・RSV診断の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・RSV診断のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・RSV診断のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・RSV診断の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・RSV診断の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The RSV Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global RSV Diagnostics size is estimated to be USD XX million in 2025 from USD XX million in 2019, with a change XX% between 2019 and 2020. The global RSV Diagnostics market size is expected to grow at a CAGR of XX% for the next five years.
Market segmentation
RSV Diagnostics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Kits and Assays
Instruments
Other
Market segment by Application, can be divided into
Hospitals & Clinics
Clinical Laboratories
Homecare
Market segment by players, this report covers
bioMérieux
Abbott
Roche
BD
Thermo Fisher
Luminex
Danaher
Biocartis
Hologic
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of RSV Diagnostics
1.2 Classification of RSV Diagnostics by Type
1.2.1 Overview: Global RSV Diagnostics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global RSV Diagnostics Revenue Market Share by Type in 2020
1.2.3 Kits and Assays
1.2.4 Instruments
1.2.5 Other
1.3 Global RSV Diagnostics Market by Application
1.3.1 Overview: Global RSV Diagnostics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals & Clinics
1.3.3 Clinical Laboratories
1.3.4 Homecare
1.4 Global RSV Diagnostics Market Size & Forecast
1.5 Global RSV Diagnostics Market Size and Forecast by Region
1.5.1 Global RSV Diagnostics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global RSV Diagnostics Market Size by Region, (2016-2021)
1.5.3 North America RSV Diagnostics Market Size and Prospect (2016-2026)
1.5.4 Europe RSV Diagnostics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific RSV Diagnostics Market Size and Prospect (2016-2026)
1.5.6 South America RSV Diagnostics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa RSV Diagnostics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 RSV Diagnostics Market Drivers
1.6.2 RSV Diagnostics Market Restraints
1.6.3 RSV Diagnostics Trends Analysis
2 Company Profiles
2.1 bioMérieux
2.1.1 bioMérieux Details
2.1.2 bioMérieux Major Business
2.1.3 bioMérieux RSV Diagnostics Product and Solutions
2.1.4 bioMérieux RSV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 bioMérieux Recent Developments and Future Plans
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business
2.2.3 Abbott RSV Diagnostics Product and Solutions
2.2.4 Abbott RSV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Abbott Recent Developments and Future Plans
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche RSV Diagnostics Product and Solutions
2.3.4 Roche RSV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Roche Recent Developments and Future Plans
2.4 BD
2.4.1 BD Details
2.4.2 BD Major Business
2.4.3 BD RSV Diagnostics Product and Solutions
2.4.4 BD RSV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 BD Recent Developments and Future Plans
2.5 Thermo Fisher
2.5.1 Thermo Fisher Details
2.5.2 Thermo Fisher Major Business
2.5.3 Thermo Fisher RSV Diagnostics Product and Solutions
2.5.4 Thermo Fisher RSV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Thermo Fisher Recent Developments and Future Plans
2.6 Luminex
2.6.1 Luminex Details
2.6.2 Luminex Major Business
2.6.3 Luminex RSV Diagnostics Product and Solutions
2.6.4 Luminex RSV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Luminex Recent Developments and Future Plans
2.7 Danaher
2.7.1 Danaher Details
2.7.2 Danaher Major Business
2.7.3 Danaher RSV Diagnostics Product and Solutions
2.7.4 Danaher RSV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Danaher Recent Developments and Future Plans
2.8 Biocartis
2.8.1 Biocartis Details
2.8.2 Biocartis Major Business
2.8.3 Biocartis RSV Diagnostics Product and Solutions
2.8.4 Biocartis RSV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Biocartis Recent Developments and Future Plans
2.9 Hologic
2.9.1 Hologic Details
2.9.2 Hologic Major Business
2.9.3 Hologic RSV Diagnostics Product and Solutions
2.9.4 Hologic RSV Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Hologic Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global RSV Diagnostics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 RSV Diagnostics Players Market Share
3.2.2 Top 10 RSV Diagnostics Players Market Share
3.2.3 Market Competition Trend
3.3 RSV Diagnostics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global RSV Diagnostics Revenue and Market Share by Type (2016-2021)
4.2 Global RSV Diagnostics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global RSV Diagnostics Revenue Market Share by Application (2016-2021)
5.2 RSV Diagnostics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America RSV Diagnostics Revenue by Type (2016-2026)
6.2 North America RSV Diagnostics Revenue by Application (2016-2026)
6.3 North America RSV Diagnostics Market Size by Country
6.3.1 North America RSV Diagnostics Revenue by Country (2016-2026)
6.3.2 United States RSV Diagnostics Market Size and Forecast (2016-2026)
6.3.3 Canada RSV Diagnostics Market Size and Forecast (2016-2026)
6.3.4 Mexico RSV Diagnostics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe RSV Diagnostics Revenue by Type (2016-2026)
7.2 Europe RSV Diagnostics Revenue by Application (2016-2026)
7.3 Europe RSV Diagnostics Market Size by Country
7.3.1 Europe RSV Diagnostics Revenue by Country (2016-2026)
7.3.2 Germany RSV Diagnostics Market Size and Forecast (2016-2026)
7.3.3 France RSV Diagnostics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom RSV Diagnostics Market Size and Forecast (2016-2026)
7.3.5 Russia RSV Diagnostics Market Size and Forecast (2016-2026)
7.3.6 Italy RSV Diagnostics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific RSV Diagnostics Revenue by Type (2016-2026)
8.2 Asia-Pacific RSV Diagnostics Revenue by Application (2016-2026)
8.3 Asia-Pacific RSV Diagnostics Market Size by Region
8.3.1 Asia-Pacific RSV Diagnostics Revenue by Region (2016-2026)
8.3.2 China RSV Diagnostics Market Size and Forecast (2016-2026)
8.3.3 Japan RSV Diagnostics Market Size and Forecast (2016-2026)
8.3.4 South Korea RSV Diagnostics Market Size and Forecast (2016-2026)
8.3.5 India RSV Diagnostics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia RSV Diagnostics Market Size and Forecast (2016-2026)
8.3.7 Australia RSV Diagnostics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America RSV Diagnostics Revenue by Type (2016-2026)
9.2 South America RSV Diagnostics Revenue by Application (2016-2026)
9.3 South America RSV Diagnostics Market Size by Country
9.3.1 South America RSV Diagnostics Revenue by Country (2016-2026)
9.3.2 Brazil RSV Diagnostics Market Size and Forecast (2016-2026)
9.3.3 Argentina RSV Diagnostics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa RSV Diagnostics Revenue by Type (2016-2026)
10.2 Middle East & Africa RSV Diagnostics Revenue by Application (2016-2026)
10.3 Middle East & Africa RSV Diagnostics Market Size by Country
10.3.1 Middle East & Africa RSV Diagnostics Revenue by Country (2016-2026)
10.3.2 Turkey RSV Diagnostics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia RSV Diagnostics Market Size and Forecast (2016-2026)
10.3.4 UAE RSV Diagnostics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global RSV Diagnostics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global RSV Diagnostics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market RSV Diagnostics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global RSV Diagnostics Revenue (USD Million) by Region (2016-2021)
Table 5. Global RSV Diagnostics Revenue Market Share by Region (2021-2026)
Table 6. bioMérieux Corporate Information, Head Office, and Major Competitors
Table 7. bioMérieux Major Business
Table 8. bioMérieux RSV Diagnostics Product and Solutions
Table 9. bioMérieux RSV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Abbott Corporate Information, Head Office, and Major Competitors
Table 11. Abbott Major Business
Table 12. Abbott RSV Diagnostics Product and Solutions
Table 13. Abbott RSV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Roche Corporate Information, Head Office, and Major Competitors
Table 15. Roche Major Business
Table 16. Roche RSV Diagnostics Product and Solutions
Table 17. Roche RSV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. BD Corporate Information, Head Office, and Major Competitors
Table 19. BD Major Business
Table 20. BD RSV Diagnostics Product and Solutions
Table 21. BD RSV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Thermo Fisher Corporate Information, Head Office, and Major Competitors
Table 23. Thermo Fisher Major Business
Table 24. Thermo Fisher RSV Diagnostics Product and Solutions
Table 25. Thermo Fisher RSV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Luminex Corporate Information, Head Office, and Major Competitors
Table 27. Luminex Major Business
Table 28. Luminex RSV Diagnostics Product and Solutions
Table 29. Luminex RSV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Danaher Corporate Information, Head Office, and Major Competitors
Table 31. Danaher Major Business
Table 32. Danaher RSV Diagnostics Product and Solutions
Table 33. Danaher RSV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Biocartis Corporate Information, Head Office, and Major Competitors
Table 35. Biocartis Major Business
Table 36. Biocartis RSV Diagnostics Product and Solutions
Table 37. Biocartis RSV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Hologic Corporate Information, Head Office, and Major Competitors
Table 39. Hologic Major Business
Table 40. Hologic RSV Diagnostics Product and Solutions
Table 41. Hologic RSV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global RSV Diagnostics Revenue (USD Million) by Players (2019-2021)
Table 43. Global RSV Diagnostics Revenue Share by Players (2019-2021)
Table 44. Breakdown of RSV Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. RSV Diagnostics Players Head Office, Products and Services Provided
Table 46. RSV Diagnostics Mergers & Acquisitions in the Past Five Years
Table 47. RSV Diagnostics New Entrants and Expansion Plans
Table 48. Global RSV Diagnostics Revenue (USD Million) by Type (2016-2021)
Table 49. Global RSV Diagnostics Revenue Share by Type (2016-2021)
Table 50. Global RSV Diagnostics Revenue Forecast by Type (2021-2026)
Table 51. Global RSV Diagnostics Revenue by Application (2016-2021)
Table 52. Global RSV Diagnostics Revenue Forecast by Application (2021-2026)
Table 53. North America RSV Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 54. North America RSV Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 55. North America RSV Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 56. North America RSV Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 57. North America RSV Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 58. North America RSV Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe RSV Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe RSV Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe RSV Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe RSV Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe RSV Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe RSV Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific RSV Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific RSV Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific RSV Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific RSV Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific RSV Diagnostics Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific RSV Diagnostics Revenue by Region (2021-2026) & (USD Million)
Table 71. South America RSV Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 72. South America RSV Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 73. South America RSV Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 74. South America RSV Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 75. South America RSV Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 76. South America RSV Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa RSV Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa RSV Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa RSV Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa RSV Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa RSV Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa RSV Diagnostics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. RSV Diagnostics Picture
Figure 2. Global RSV Diagnostics Revenue Market Share by Type in 2020
Figure 3. Kits and Assays
Figure 4. Instruments
Figure 5. Other
Figure 6. RSV Diagnostics Revenue Market Share by Application in 2020
Figure 7. Hospitals & Clinics Picture
Figure 8. Clinical Laboratories Picture
Figure 9. Homecare Picture
Figure 10. Global RSV Diagnostics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global RSV Diagnostics Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global RSV Diagnostics Revenue Market Share by Region (2016-2026)
Figure 13. Global RSV Diagnostics Revenue Market Share by Region in 2020
Figure 14. North America RSV Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe RSV Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific RSV Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America RSV Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. RSV Diagnostics Market Drivers
Figure 19. RSV Diagnostics Market Restraints
Figure 20. RSV Diagnostics Market Trends
Figure 21. bioMérieux Recent Developments and Future Plans
Figure 22. Abbott Recent Developments and Future Plans
Figure 23. Roche Recent Developments and Future Plans
Figure 24. BD Recent Developments and Future Plans
Figure 25. Thermo Fisher Recent Developments and Future Plans
Figure 26. Luminex Recent Developments and Future Plans
Figure 27. Danaher Recent Developments and Future Plans
Figure 28. Biocartis Recent Developments and Future Plans
Figure 29. Hologic Recent Developments and Future Plans
Figure 31. Global RSV Diagnostics Revenue Share by Players in 2020
Figure 32. RSV Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 33. Global Top 3 Players RSV Diagnostics Revenue Market Share in 2020
Figure 34. Global Top 10 Players RSV Diagnostics Revenue Market Share in 2020
Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 36. Global RSV Diagnostics Revenue Share by Type in 2020
Figure 37. Global RSV Diagnostics Market Share Forecast by Type (2021-2026)
Figure 38. Global RSV Diagnostics Revenue Share by Application in 2020
Figure 39. Global RSV Diagnostics Market Share Forecast by Application (2021-2026)
Figure 40. North America RSV Diagnostics Sales Market Share by Type (2016-2026)
Figure 41. North America RSV Diagnostics Sales Market Share by Application (2016-2026)
Figure 42. North America RSV Diagnostics Revenue Market Share by Country (2016-2026)
Figure 43. United States RSV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada RSV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico RSV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe RSV Diagnostics Sales Market Share by Type (2016-2026)
Figure 47. Europe RSV Diagnostics Sales Market Share by Application (2016-2026)
Figure 48. Europe RSV Diagnostics Revenue Market Share by Country (2016-2026)
Figure 49. Germany RSV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France RSV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom RSV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia RSV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy RSV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific RSV Diagnostics Sales Market Share by Type (2016-2026)
Figure 55. Asia-Pacific RSV Diagnostics Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific RSV Diagnostics Revenue Market Share by Region (2016-2026)
Figure 57. China RSV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan RSV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South Korea RSV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India RSV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia RSV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia RSV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America RSV Diagnostics Sales Market Share by Type (2016-2026)
Figure 64. South America RSV Diagnostics Sales Market Share by Application (2016-2026)
Figure 65. South America RSV Diagnostics Revenue Market Share by Country (2016-2026)
Figure 66. Brazil RSV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina RSV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East and Africa RSV Diagnostics Sales Market Share by Type (2016-2026)
Figure 69. Middle East and Africa RSV Diagnostics Sales Market Share by Application (2016-2026)
Figure 70. Middle East and Africa RSV Diagnostics Revenue Market Share by Country (2016-2026)
Figure 71. Turkey RSV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Saudi Arabia RSV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. UAE RSV Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Methodology
Figure 75. Research Process and Data Source
世界のRSV診断市場規模・現状・予測（2021年-2027年） Because mild RSV symptoms are similar to the common cold, testing usually isn't required to diagnose the infection. However, your doctor may suspect RSV based on your medical history, time of year and a physical exam. In this case, they may want to run lab tests to confirm the diagnosis. The most co…- 世界の呼吸器診断市場 2021：企業別、地域別、種類・用途別 The Respiratory Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 世界の呼吸器診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Respiratory Diagnostics Market The global Respiratory Diagnostics market size is projected to reach US$ 7061.2 million by 2026, from US$ 5298.8 million in 2019, at a CAGR of 4.1% during 2021-2026. With industry-standard accuracy in analysis and high data integrit…
- 世界のポイントオブケア診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Point-of-Care Diagnostics Market The global Point-of-Care Diagnostics market size is projected to reach US$ 33460 million by 2026, from US$ 22640 million in 2019, at a CAGR of 5.7% during 2021-2026. With industry-standard accuracy in analysis and high data integr…
- 世界のがん用体外診断 (IVD)市場 2021：企業別、地域別、種類・用途別 The In-Vitro Cancer Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…